AIDS vaccine not as effective as first thought.

AIDS vaccine not as effective as first thought, scientists say A vaccine to safeguard against HIV may not be as effective as first thought, scientists said Tuesday . The Wall Street Journal: ‘When first publicly disclosing the outcome of the vaccine trial in September, researchers said the vaccine experienced lowered the risk of disease by about 31 percent. That result was modest but statistically significant.’ Two other analyses of the data have found, nevertheless, that the significance of the trials could be attributed to statistical chance.

Last year, the world spent $16 billion on the duty of combating AIDS, half of which was donated by rich charities and countries. A recent projection approximated that, by 2031, global AIDS costs could reach the same as $35 billion a 12 months. While that is not even half the 14. About 33.3 million people around the world are infected with HIV, the virus that causes AIDS. In 2009 2009, the last year that there are complete statistics, 2.6 million people became infected and 1.8 million people died. Those true numbers are straight down from previous peaks. Related StoriesKey part of MRSA vaccine puzzle unearthedUC Irvine Health researchers develop one-step check to detect HCV infectionsNew vaccine applicant shows great guarantee at fighting respiratory syncytial virusNevertheless, the amount of people living with HIV is still on the increase.